Skip to main content

Table 1 The pathology scores of pancreases in each group on day 4 after treatment

From: Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models

Groups Edema (Mean ± SD) Necrosis (Mean ± SD) Inflammation (Mean ± SD) Hemorrhage (Mean ± SD) Total (Mean ± SD)
Group1 0.00 ± 0.00 0.50 ± 0.58 0.00 ± 0.00 0.25 ± 0.50 0.75 ± 0.50
Group1’ 0.50 ± 0.41 0.00 ± 0.00 0.50 ± 0.58 0.00 ± 0.00 1.00 ± 0.91
Group2 0.38 ± 0.25 0.00 ± 0.00 0.50 ± 0.58 0.50 ± 0.58 1.38 ± 1.03
Group2’ 0.25 ± 0.29 0.25 ± 0.50 0.25 ± 0.50 0.50 ± 0.58 1.25 ± 1.19
Group3 0.63 ± 0.63 * 0.00 ± 0.00 1.00 ± 0.82 * 0.25 ± 0.50 1.88 ± 1.80
Group3’ 0.63 ± 0.48 * 0.25 ± 0.50 1.25 ± 0.96 * 0.25 ± 0.50 2.38 ± 1.25 *
Group4 0.88 ± 0.25 * 0.00 ± 0.00 0.75 ± 0.50 0.25 ± 0.50 1.88 ± 0.85
Group4’ 0.88 ± 0.25 * 0.50 ± 0.58 1.75 ± 0.50 * 0.00 ± 0.00 3.13 ± 0.63 *
  1. *P < 0.05, compared with group 1